
Benjamin L. Lebron
Examiner (ID: 7336, Phone: (571)272-0475 , Office: P/1777 )
| Most Active Art Unit | 1777 |
| Art Unit(s) | 1777, 1773 |
| Total Applications | 617 |
| Issued Applications | 402 |
| Pending Applications | 48 |
| Abandoned Applications | 180 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7038957
[patent_doc_number] => 20050158391
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-21
[patent_title] => 'Azithromycin multiparticulate dosage forms by melt-congeal processes'
[patent_app_type] => utility
[patent_app_number] => 11/003856
[patent_app_country] => US
[patent_app_date] => 2004-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22338
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20050158391.pdf
[firstpage_image] =>[orig_patent_app_number] => 11003856
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/003856 | Azithromycin multiparticulate dosage forms by melt-congeal processes | Dec 2, 2004 | Abandoned |
Array
(
[id] => 6905209
[patent_doc_number] => 20050100604
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-12
[patent_title] => 'Production method for sustained-release preparation'
[patent_app_type] => utility
[patent_app_number] => 11/001889
[patent_app_country] => US
[patent_app_date] => 2004-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11023
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20050100604.pdf
[firstpage_image] =>[orig_patent_app_number] => 11001889
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/001889 | Production method for sustained-release preparation | Dec 1, 2004 | Abandoned |
Array
(
[id] => 7038822
[patent_doc_number] => 20050158256
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-21
[patent_title] => 'Cosmetics tester and method of manufacturing such a tester'
[patent_app_type] => utility
[patent_app_number] => 11/001009
[patent_app_country] => US
[patent_app_date] => 2004-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2027
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20050158256.pdf
[firstpage_image] =>[orig_patent_app_number] => 11001009
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/001009 | Cosmetics tester and method of manufacturing such a tester | Dec 1, 2004 | Abandoned |
Array
(
[id] => 7112208
[patent_doc_number] => 20050209664
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'Electrical devices and anti-scarring agents'
[patent_app_type] => utility
[patent_app_number] => 10/998349
[patent_app_country] => US
[patent_app_date] => 2004-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 140794
[patent_no_of_claims] => 112
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20050209664.pdf
[firstpage_image] =>[orig_patent_app_number] => 10998349
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/998349 | Electrical devices and anti-scarring agents | Nov 25, 2004 | Abandoned |
Array
(
[id] => 5224745
[patent_doc_number] => 20070254011
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-01
[patent_title] => 'Bone Formation Agent and Method of Production'
[patent_app_type] => utility
[patent_app_number] => 10/580549
[patent_app_country] => US
[patent_app_date] => 2004-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6534
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20070254011.pdf
[firstpage_image] =>[orig_patent_app_number] => 10580549
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/580549 | Bioabsorbable composite material | Nov 24, 2004 | Issued |
Array
(
[id] => 6990539
[patent_doc_number] => 20050089576
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-28
[patent_title] => 'Sustained release formulation of a peptide'
[patent_app_type] => utility
[patent_app_number] => 10/990033
[patent_app_country] => US
[patent_app_date] => 2004-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6684
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0089/20050089576.pdf
[firstpage_image] =>[orig_patent_app_number] => 10990033
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/990033 | Sustained release formulation of a peptide | Nov 15, 2004 | Abandoned |
Array
(
[id] => 7098549
[patent_doc_number] => 20050131008
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-16
[patent_title] => '42-O-alkoxyalkyl rapamycin derivatives and compositions comprising same'
[patent_app_type] => utility
[patent_app_number] => 10/987771
[patent_app_country] => US
[patent_app_date] => 2004-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 14868
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0131/20050131008.pdf
[firstpage_image] =>[orig_patent_app_number] => 10987771
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/987771 | 42-O-alkoxyalkyl rapamycin derivatives and compositions comprising same | Nov 11, 2004 | Abandoned |
Array
(
[id] => 7773085
[patent_doc_number] => 08119161
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-02-21
[patent_title] => 'Blister pack and solid dosage form therefor'
[patent_app_type] => utility
[patent_app_number] => 10/519715
[patent_app_country] => US
[patent_app_date] => 2004-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2390
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/119/08119161.pdf
[firstpage_image] =>[orig_patent_app_number] => 10519715
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/519715 | Blister pack and solid dosage form therefor | Nov 11, 2004 | Issued |
Array
(
[id] => 5865117
[patent_doc_number] => 20060099247
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-11
[patent_title] => 'Liquid, gas and/or vapor phase delivery systems'
[patent_app_type] => utility
[patent_app_number] => 10/986101
[patent_app_country] => US
[patent_app_date] => 2004-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12798
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20060099247.pdf
[firstpage_image] =>[orig_patent_app_number] => 10986101
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/986101 | Liquid, gas and/or vapor phase delivery systems | Nov 9, 2004 | Abandoned |
Array
(
[id] => 4989433
[patent_doc_number] => 20070155774
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-05
[patent_title] => 'Oral formulations of desoxypeganine and thereof uses'
[patent_app_type] => utility
[patent_app_number] => 10/580485
[patent_app_country] => US
[patent_app_date] => 2004-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3123
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0155/20070155774.pdf
[firstpage_image] =>[orig_patent_app_number] => 10580485
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/580485 | Oral formulations of desoxypeganine and thereof uses | Nov 7, 2004 | Abandoned |
Array
(
[id] => 7105176
[patent_doc_number] => 20050107352
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-19
[patent_title] => 'Method of treating benign prostatic hyperplasia'
[patent_app_type] => utility
[patent_app_number] => 10/980570
[patent_app_country] => US
[patent_app_date] => 2004-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4042
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0107/20050107352.pdf
[firstpage_image] =>[orig_patent_app_number] => 10980570
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/980570 | Method of treating benign prostatic hyperplasia | Nov 1, 2004 | Abandoned |
Array
(
[id] => 5912417
[patent_doc_number] => 20060127479
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-15
[patent_title] => 'Solvent free taste masked pharmaceutical compositions'
[patent_app_type] => utility
[patent_app_number] => 10/961728
[patent_app_country] => US
[patent_app_date] => 2004-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4851
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0127/20060127479.pdf
[firstpage_image] =>[orig_patent_app_number] => 10961728
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/961728 | Solvent free taste masked pharmaceutical compositions | Oct 7, 2004 | Abandoned |
Array
(
[id] => 7250505
[patent_doc_number] => 20050142192
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-30
[patent_title] => 'Oral administration of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl] phosphonic acid and derivatives'
[patent_app_type] => utility
[patent_app_number] => 10/961871
[patent_app_country] => US
[patent_app_date] => 2004-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 16554
[patent_no_of_claims] => 108
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20050142192.pdf
[firstpage_image] =>[orig_patent_app_number] => 10961871
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/961871 | Oral administration of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl] phosphonic acid and derivatives | Oct 7, 2004 | Abandoned |
Array
(
[id] => 6938632
[patent_doc_number] => 20050112195
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Drug coating providing high drug loading and methods for providing same'
[patent_app_type] => utility
[patent_app_number] => 10/950003
[patent_app_country] => US
[patent_app_date] => 2004-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11193
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20050112195.pdf
[firstpage_image] =>[orig_patent_app_number] => 10950003
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/950003 | Drug coating providing high drug loading | Sep 22, 2004 | Issued |
Array
(
[id] => 4553967
[patent_doc_number] => 07838033
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-11-23
[patent_title] => 'Composition for rapid disintegrating tablet in oral cavity'
[patent_app_type] => utility
[patent_app_number] => 10/945049
[patent_app_country] => US
[patent_app_date] => 2004-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 10465
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/838/07838033.pdf
[firstpage_image] =>[orig_patent_app_number] => 10945049
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/945049 | Composition for rapid disintegrating tablet in oral cavity | Sep 20, 2004 | Issued |
Array
(
[id] => 5827157
[patent_doc_number] => 20060062845
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-23
[patent_title] => 'Alfuzosin tablets and synthesis'
[patent_app_type] => utility
[patent_app_number] => 10/943725
[patent_app_country] => US
[patent_app_date] => 2004-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5032
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0062/20060062845.pdf
[firstpage_image] =>[orig_patent_app_number] => 10943725
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/943725 | Alfuzosin tablets and synthesis | Sep 16, 2004 | Abandoned |
Array
(
[id] => 4548112
[patent_doc_number] => 07820200
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-10-26
[patent_title] => 'Pharmaceutical composition for the sustained release of hydralazine and use thereof as a support for cancer treatment'
[patent_app_type] => utility
[patent_app_number] => 11/575016
[patent_app_country] => US
[patent_app_date] => 2004-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2790
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/820/07820200.pdf
[firstpage_image] =>[orig_patent_app_number] => 11575016
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/575016 | Pharmaceutical composition for the sustained release of hydralazine and use thereof as a support for cancer treatment | Sep 8, 2004 | Issued |
Array
(
[id] => 7208904
[patent_doc_number] => 20050053639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-10
[patent_title] => 'Partially absorbable fiber-reinforced composites for controlled drug delivery'
[patent_app_type] => utility
[patent_app_number] => 10/935808
[patent_app_country] => US
[patent_app_date] => 2004-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5803
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20050053639.pdf
[firstpage_image] =>[orig_patent_app_number] => 10935808
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/935808 | Partially absorbable fiber-reinforced composites for controlled drug delivery | Sep 7, 2004 | Issued |
Array
(
[id] => 5710056
[patent_doc_number] => 20060051401
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-09
[patent_title] => 'Controlled nanofiber seeding'
[patent_app_type] => utility
[patent_app_number] => 10/936437
[patent_app_country] => US
[patent_app_date] => 2004-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13416
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0051/20060051401.pdf
[firstpage_image] =>[orig_patent_app_number] => 10936437
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/936437 | Controlled nanofiber seeding | Sep 6, 2004 | Abandoned |
Array
(
[id] => 5709953
[patent_doc_number] => 20060051298
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-09
[patent_title] => 'Abuse resistent pharmaceutical dosage and method of making same'
[patent_app_type] => utility
[patent_app_number] => 10/934223
[patent_app_country] => US
[patent_app_date] => 2004-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2105
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0051/20060051298.pdf
[firstpage_image] =>[orig_patent_app_number] => 10934223
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/934223 | Abuse resistent pharmaceutical dosage and method of making same | Sep 2, 2004 | Abandoned |